Markets:

Overview

News

Currencies

International

Treasuries

Co-Diagnostics, Inc. - Common Stock (NQ:CODX)

1.295 +0.035 (+2.78%)

Streaming Delayed Price Updated: 12:09 PM EDT, Aug 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Co-Diagnostics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 10, 2023

Via Benzinga

Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year ↗

September 21, 2023

In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.

Via Benzinga

7 Doomed Growth Stocks Destined for Disaster ↗

July 12, 2023

Investing in growth stocks can be very expensive. Save yourself some time and money by avoiding these doomed growth stocks to sell.

Via InvestorPlace

Preview: Co-Diagnostics's Earnings ↗

May 10, 2023

Via Benzinga

Co-Diagnostics Earnings Perspective: Return On Invested Capital ↗

March 17, 2023

Via Benzinga

Preview: Co-Diagnostics's Earnings ↗

March 15, 2023

Via Benzinga

Spectrum Brands, Sanmina And 3 Stocks To Watch Heading Into Friday ↗

May 12, 2023

With US stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 20, 2023 ↗

March 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 08, 2023

Via Benzinga

Co-Diagnostics, Inc. (NASDAQ:CODX) Long Term Shareholder Notice: Investigation over Possible Wrongdoing ↗

November 18, 2022

San Diego, CA -- (SBWIRE) -- 11/18/2022 -- Certain directors of Co-Diagnostics, Inc are under investigation over potential breaches of fiduciary duties.

Via SBWire

Co-Diagnostics's Earnings Outlook ↗

November 09, 2022

Co-Diagnostics (NASDAQ:CODX) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm

October 16, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

CODX FINAL DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Co-Diagnostics, Inc. Investors With Losses to Secure Counsel Before Important Monday Deadline in Securities Class Action - CODX

October 15, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

CO-DX DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Co-Diagnostics, Inc. and Encourages Investors to Contact the Firm

October 14, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Co-Diagnostics, Inc. (CODX) and Encourages Long-Term CODX Investors to Contact the Firm

October 13, 2022

From Kaskela Law LLC

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm

October 11, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

CODX DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action - CODX

October 08, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm

October 05, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

CODX FINAL DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action - CODX

October 05, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm

October 02, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX

October 02, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests ↗

September 27, 2022

Via Benzinga

7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’ ↗

September 27, 2022

Investors have seven widely-followed vaccine stocks to sell now, after the world decided the pandemic is over.

Via InvestorPlace

CODX NOTICE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX

September 26, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns ↗

September 23, 2022

The World Health Organization (WHO) warned that it struggles to identify and

Via Benzinga

CODX INVESTOR NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX

September 21, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

ROSEN, A TOP RANKED LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX

September 10, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Co-Diagnostics's Return On Capital Employed Overview ↗

September 07, 2022

Benzinga Pro data, Co-Diagnostics (NASDAQ:CODX) reported Q2 sales of $5.02 million. Earnings fell to a loss of $2.69 million, resulting in a 122.93% decrease from last quarter.

Via Benzinga

ROSEN, LEADING INVESTOR COUNSEL, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX

September 05, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Co-Diagnostics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – CODX

August 29, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Co-Diagnostics, Inc. - Common Stock (NQ:CODX)

All News about Co-Diagnostics, Inc. - Common Stock

Starting at /week.